Genagon Therapeutics
Solna, Stockholms Lan, Sweden
About Genagon Therapeutics
Genagon Therapeutics is developing a brand new unique method for the treatment of cancer. Genagon, which originates in research at Uppsala University and Karolinska Institutet, develops biological drugs such as antibodies in inflammation and cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $233.9K
- Funding stage: Seed
- Last round: Seed (Jan 2016)
- Website: genagon.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/genagon-therapeutics-2511021 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.